[ad_1]
London:
Britain’s medical regulator will study all the info from trials of the COVID-19 vaccine developed by Oxford and AstraZeneca, together with which dosing routine is finest to make use of, the regulator’s chief govt stated on Wednesday.
“Our regulatory review is all encompassing We will look at all available data,” June Raine, chief govt of the Medicines and Healthcare merchandise Regulatory Agency (MHRA), advised lawmakers after a research confirmed the vaccine had efficacy of 62% for trial contributors given two full doses, however 90% for a smaller sub-group given a half, then a full dose.
“Clearly, we have great interest into the possible reasons for the different doses having a different efficacy,” she stated.
“The position is we will look at every piece of evidence part of that will be to examine with great rigour, the basis for the appropriate dosage regimen,” she added.
(Except for the headline, this story has not been edited by NDTV workers and is printed from a syndicated feed.)
[ad_2]
Source hyperlink